Instrument Inactif

Autres langues Galapagos NV Euronext Bruxelles

Actions

GLPG

BE0003818359

Cours en clôture Euronext Bruxelles Autres places de cotation
-	-

31/05	Galapagos et Adaptimmune vont développer conjointement un traitement contre le cancer de la tête et du cou	MT
20/05	AVIS D'ANALYSTES DU JOUR : Scor, Ubisoft, Nvidia, Richemont, Micron Technology...

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Galapagos, Adaptimmune to Jointly Develop Head, Neck Cancer Treatment	31/05
AVIS D'ANALYSTES DU JOUR : Scor, Ubisoft, Nvidia, Richemont, Micron Technology...	20/05
Galapagos Partners with Blood Centers of America to Decentralize CAR-T Cell Therapy Manufacture	16/05
Galapagos and Blood Centers of America Announce Strategic Collaboration to Accelerate Galapagos? Decentralized Car-T Manufacturing Network in the U.S	15/05
Transcript : Galapagos NV, Q1 2024 Earnings Call, May 03, 2024	03/05
Galapagos NV Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05
Galapagos Showcases Innovative Approach in Hematological Cancer Care with Clinical and Translational Data Presentations at EBMT Congress 2024	08/04
Galapagos Continues to be 'Value Trap' With Unclear Growth Path, BofA Says	28/03
GALAPAGOS NV : BofA Securities révise son opinion et passe à vendre	28/03
Galapagos NV Announces Board Changes	27/03
AVIS D'ANALYSTES DU JOUR : Stellantis, Accor, Eiffage, Teleperformance, McPhy, Tod's, Ferrari....	13/03
AVIS D'ANALYSTES DU JOUR : Accor, Air Liquide, Legrand, Engie, Alten, BE Semi, Roche...	26/02
Galapagos to Seek Acquisitions	23/02
Transcript : Galapagos NV, 2023 Earnings Call, Feb 23, 2024	23/02
Galapagos NV Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Galapagos NV to Present New Preliminary Translational Data at EBMT-EHA Annual Meeting 2024	15/02
Galapagos Completes Sale of Jyseleca Business to Alfasigma	01/02
Alfasigma S.p.A. completed the acquisition of Filgotinib business from Galapagos NV.	31/01
Galapagos NV Enters into Strategic Collaboration Agreement with Thermo Fisher Scientific, Inc. to Further Expand Its Decentralized CAR-T Manufacturing Network in the U.S	05/01
C'est pas bientaux fini ?	05/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Galapagos NV Euronext Bruxelles

Actions

GLPG

BE0003818359

Autres langues

Filtres